Elsevier’s MC Strategies Enhances Its ICD-10 Roadmap
Elsevier to exhibit new, expanded readiness assessment and clinical documentation curriculum at its Destination: ICD-10 booth at upcoming AHIMA convention
Atlanta, GA, Sept. 27, 2012 – Elsevier’s MC Strategies, a leader in providing eLearning solutions to more than 1,300 healthcare organizations, today announced the continued development of its ICD-10 Roadmap with the introduction of new curricula, including a comprehensive clinical documentation curriculum.
At its exhibit at the 84th AHIMA Convention (Booth #626, Chicago, Oct. 1-3), Elsevier will unveil its new EduCode Clinical Documentation Improvement eLearning curriculum. Providing the right information for coding and reimbursement is critical with the increased specificity of ICD-10, and clinical documentation will be even more challenging. This new curriculum will be supported by additional resources, including Clinical Documentation webinars and a white paper available in October.
“At Elsevier, we’ve been a leader in educating healthcare organizations on coding practices for more than 20 years. We understand the workflow and know how to lessen the risk and fear that comes with potential change, particularly a change as fundamental as ICD-10,” said John Schrefer, President of Elsevier’s MC Strategies. “This ongoing sharing of knowledge through our new and updated curricula, white papers and webinars will keep our customers current as we help them prepare for this transition. We’re all on this journey, and we want to help prepare organizations the best we can.”
Extending that journey theme, Elsevier will continue to take entries in its “Destination: ICD-10” contest at AHIMA. The contest invites participants to complete a series of ICD-10 surveys and provides a chance to win up to $3,000 in travel money or travel-themed giveaways.
In addition to Elsevier’s continued commitment to providing the best education and resources to ensure a successful transition to ICD-10, AHIMA attendees will see new and updated versions of Elsevier’s Medical Terminology 2.0, ICD-10 Orientation, ICD-10 Specialty Coding Courses (Phase II), a revised and expanded ICD-10 Readiness Assessment (more questions, increased focus on ICD-10-specific topics and improved functionality), and major re-writes of Anatomy & Physiology and Pathophysiology courses.
To stay current with the ICD-10 transition, please find Elsevier ICD-10 on Facebook at http://www.facebook.com/ICD10Online and on Twitter at @ICD10Online. For more information about Revenue Cycle eLearning’s ICD-10 Solutions, including purchasing information, please visit www.ICD-10online.com or call +1 866 429 3067.
# # #
About Elsevier Clinical Decision Support
Elsevier Clinical Decision Support ( www.clinicaldecisionsupport.com), a division of Elsevier, the global leader in medical and health information, provides world class information and point-of-care technology solutions that optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care. The business delivers on this promise through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
Director, Corporate Relations
+1 212 633 3164